Biondo Investment Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-22,082
Closed -$2.79M 81
2018
Q2
$2.79M Buy
22,082
+1,300
+6% +$158K 0.7% 43
2018
Q1
$2.25M Sell
20,782
-14,925
-42% -$1.65M 0.59% 48
2017
Q4
$3.91M Sell
35,707
-2,720
-7% -$271K 0.99% 34
2017
Q3
$3.79M Sell
38,427
-5,210
-12% -$505K 1.04% 30
2017
Q2
$4.42M Buy
43,637
+980
+2% +$106K 1.28% 24
2017
Q1
$5.29M Sell
42,657
-1,770
-4% -$206K 1.89% 15
2016
Q4
$5.33M Sell
44,427
-90
-0.2% -$9.96K 1.76% 15
2016
Q3
$5M Buy
44,517
+1,760
+4% +$203K 1.69% 17
2016
Q2
$5.3M Buy
42,757
+2,435
+6% +$294K 1.89% 15
2016
Q1
$4.53M Buy
40,322
+2,455
+6% +$255K 1.72% 17
2015
Q4
$4.12M Sell
37,867
-2,915
-7% -$334K 1.37% 21
2015
Q3
$4.08M Sell
40,782
-1,903
-4% -$207K 1.36% 22
2015
Q2
$4.87M Buy
42,685
+545
+1% +$66.1K 1.46% 18
2015
Q1
$4.4M Buy
42,140
+2,365
+6% +$252K 1.31% 20
2014
Q4
$4.79M Sell
39,775
-6,295
-14% -$827K 1.44% 18
2014
Q3
$6.74M Buy
46,070
+4,670
+11% +$721K 2.07% 14
2014
Q2
$6.92M Buy
41,400
+11,595
+39% +$2.06M 2.18% 15
2014
Q1
$5.92M Buy
29,805
+10,065
+51% +$1.9M 1.96% 15
2013
Q4
$3.77M Buy
19,740
+1,550
+9% +$288K 1.29% 21
2013
Q3
$3.08M Buy
18,190
+5,980
+49% +$928K 1.17% 20
2013
Q2
$1.85M Buy
+12,210
New +$1.73M 0.8% 25

Other funds holding CLB

Biondo Investment Advisors's CLB Position: Q3 2018 in Review

Biondo Investment Advisors sold out of Core Laboratories (CLB) in Q3 2018, closing a stake of 22,082 shares — an estimated $2.79M sold.

Biondo Investment Advisors first reported a position in CLB in Q2 2013 and held it in 21 quarters. The position peaked at $6.92M in Q2 2014. 360 funds tracked by Wall St. Rank hold CLB as of Q3 2018.

  • Biondo Investment Advisors reported no remaining Core Laboratories position as of Q3 2018 after selling out during the quarter.
  • Biondo Investment Advisors sold 22,082 Core Laboratories shares in Q3 2018, an estimated $2.79M.
  • Biondo Investment Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 21 quarters.
  • Biondo Investment Advisors's Core Laboratories position peaked at $6.92M in Q2 2014.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2018.

Based on Biondo Investment Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.